Our new website: www.lumistarbiotech.com
LumiSTAR is developing a pipeline of innovative cell therapies based on induced pluripotent stem cell (iPSC) technology. These therapies have the potential to revolutionize the treatment of a wide range of diseases, including neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases, Kidney disease and cancer.
Other than cell therapy, the company also equipped with iPSC and bioimaging-based high throughput drug screening platform to develop new drugs. The platform uses iPSC to create disease models and 3D organoids for drug discovery and screening, allowing for more accurate and efficient identification of potential drug candidates.